Keep informed about the latest topics in global health.
#VaccinesWork
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
African Vaccine Manufacturing Accelerator (AVMA)
COVID-19
The Global Vaccine Impact Conference explained
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
FEATURED STORY
Everything you need to know about Gavi's incoming CEO, Dr Sania Nishtar
VACCINE PROFILES
Read series
KEY PUBLICATION
The 2023 Mid-Term Review Report
PROGRESS REPORT
5 June 2014
GAVI Alliance thanks Norway for its support to the polio endgame strategy
23 May 2014
Germany to host key GAVI Alliance replenishment event
6 May 2014
GAVI Alliance welcomes availability of Indian pentavalent vaccine
28 April 2014
First ever Phase III dengue fever vaccine trial complete
28 February 2014
Joint GPEI-GAVI statement on the Availability and Price of Inactivated Polio Vaccine
30 January 2014
India commits US$ 4 million to GAVI Alliance vaccine programmes
7 December 2013
Pneumococcal vaccine to protect more than a million children in Afghanistan from leading child killer
6 December 2013
GAVI Alliance pays tribute to Nelson Mandela
28 November 2013
Guillaume Grosso appointed head resource mobilisation in European markets
26 November 2013
GAVI Alliance to support Nigeria's first new national yellow fever vaccination campaign in 30 years
7 November 2013
GAVI Alliance welcomes Germany’s continued commitment to immunisation
5 November 2013
GAVI Alliance welcomes introduction of two life-saving vaccines in Senegal